0001628280-21-020070.txt : 20211014
0001628280-21-020070.hdr.sgml : 20211014
20211014171811
ACCESSION NUMBER: 0001628280-21-020070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211012
FILED AS OF DATE: 20211014
DATE AS OF CHANGE: 20211014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLANAGAN JOSEPH GERARD
CENTRAL INDEX KEY: 0001413644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34746
FILM NUMBER: 211324027
MAIL ADDRESS:
STREET 1: C/O NORTEL NETWORKS CORPORATION
STREET 2: 195 THE WEST MALL
CITY: TORONTO
STATE: A6
ZIP: M9C 5K1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: R1 RCM INC.
CENTRAL INDEX KEY: 0001472595
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 020698101
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 401 NORTH MICHIGAN AVENUE
STREET 2: SUITE 2700
CITY: CHICAGO
STATE: IL
ZIP: 60611
BUSINESS PHONE: 312-324-7820
MAIL ADDRESS:
STREET 1: 401 NORTH MICHIGAN AVENUE
STREET 2: SUITE 2700
CITY: CHICAGO
STATE: IL
ZIP: 60611
FORMER COMPANY:
FORMER CONFORMED NAME: Accretive Health, Inc.
DATE OF NAME CHANGE: 20090918
4
1
wf-form4_163424626599988.xml
FORM 4
X0306
4
2021-10-12
0
0001472595
R1 RCM INC.
RCM
0001413644
FLANAGAN JOSEPH GERARD
C/O R1 RCM INC.
434 W. ASCENSION WAY, 6TH FLOOR
MURRAY
UT
84123
1
1
0
0
President and CEO
Common Stock
2021-10-12
4
M
0
78703
2.42
A
2589039
D
Common Stock
2021-10-12
4
S
0
78703
23.13
D
2510336
D
Common Stock
2021-10-13
4
M
0
30699
2.42
A
2541035
D
Common Stock
2021-10-13
4
S
0
30699
23.075
D
2510336
D
Common Stock
2021-10-14
4
M
0
21115
2.42
A
2531451
D
Common Stock
2021-10-14
4
S
0
21115
23.076
D
2510336
D
Stock Option (right to buy)
2.42
2021-10-12
4
M
0
78703
0
D
2026-10-03
Common Stock
78703.0
738687
D
Stock Option (right to buy)
2.42
2021-10-13
4
M
0
30699
0
D
2026-10-03
Common Stock
30699.0
707988
D
Stock Option (right to buy)
2.42
2021-10-14
4
M
0
21115
0
D
2026-10-03
Common Stock
21115.0
686873
D
The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.36 per share. The reporting person undertakes to provide to R1 RCM Inc., any security holder of R1 RCM Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.23 per share. The reporting person undertakes to provide to R1 RCM Inc., any security holder of R1 RCM Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The stock options vested and became exercisable in equal annual installments on April 1, 2017, 2018, 2019 and 2020.
/s/ E. Terry Platis, Attorney-in-Fact
2021-10-14